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Abstract
Fractionated excretory/secretory products (ES) of adult Haemonchus contortus were evaluated as protective antigens. The proteins
were successively eluted from a Thiol Sepharose column using 25 mM cysteine followed by 25 mM Dl-dithiothreitol (DTT). Sheep were
vaccinated three times and challenged with 5000 third stage infective larvae (L3) of H. contortus. Highest level of protection was found in
sheep vaccinated with the DTT-eluted fraction in which egg output and worm burden were reduced by 52 and 50%, respectively, compared
to the adjuvant control group. There was a positive correlation between fecundity (number of eggs per female) and the cumulative EPG
or worm burden. Serum and mucus antibody levels of ES-specific immunoglobulins increased after immunizations and after challenge for
IgG, IgA and IgE. The harvesting of H. contortus from animals clustered per group revealed the presence of cysteine protease activity
in the ES of all groups but in addition to that, metalloprotease activity was also detected in the groups vaccinated with the DTT-eluted
fraction, total ES and adjuvant only, in contrast to previous batches of ES (completely inhibited by E64) obtained from non vaccinated
animals.
© 2003 Elsevier Ltd. All rights reserved.
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1. Introduction
Haemonchus contortus is a blood-sucking nematode that
primarily infects the abomasum of sheep and goats world-
wide. Infections with this parasite can cause, mainly in
young animals, anaemia and weight loss that in some cases
result in death. Anthelmintic resistance has been detected
in several H. contortus strains [1,2] and concerns about
the effects of the residues on the health of consumers have
focussed attention on the development of a vaccine. Some
antigens have been tested with considerable success includ-
ing gut proteins such as microsomal aminopeptidase H11
[3], glycoprotein complex H-gal-GP [4] as well as larval
antigens [5]. Total excretory/secretory products (ES), or
partially ES components such as 15 and 24 kDa proteins
(Hc15 and Hc24) have also been tested with considerable
promise [6]. Most of these antigens are major constituents
of protein fractions obtained by sub cellular fractionations
∗ Corresponding author. Tel: +31-30-2532582; fax: +31-30-2540784.
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and/or ion exchange chromatography. Analysis of the com-
plexity of these enriched fractions mainly relied on rather
insensitive evaluation of 1D gels [3–6]. Consequently, the
contribution of many unidentified proteins to protection
observed in vaccination experiments remains undetermined.
Protein fractionation by virtue of covalent thiol-binding
properties is a highly specific method resulting in the
complete removal of many individual proteins. Recently,
Ostertagia ostertagi thiol-binding protein extracts from
adult membrane extracts and ES of adult worms were
tested in a vaccination trial in bovine [7]. The thiol-binding
fraction from ES induced a reduction in faecal egg count
(EPG) of 60%, whilst adult membrane extracts had
no protective effect. In contrast, Triton X-100-soluble
membrane-associated thiol-binding fractions of H. con-
tortus protected sheep against a challenge infection with
H. contortus, while water-soluble and Tween 20-soluble
membrane associated fractions induced no protection
[8]. Thiol-binding fractions of H. contortus have been
shown to be enriched in cysteine protease activity [7,8].
These proteases have attracted interest because they may
0264-410X/$ – see front matter © 2003 Elsevier Ltd. All rights reserved.
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be critical for the life cycle or pathogenicity of many
nematodes and trematodes. The ability to degrade host
proteins like haemoglobin suggested a function of cysteine
proteases in parasite nutrition [9–12]. Analysis of ESTs
of H. contortus indicated the abundance of cysteine pro-
teases, representing 17% of the sequences from a gut cDNA
library [13] and almost 5% from a total worm cDNA lib-
rary (http://nema.cap.ed.ac.uk/nematodeESTs/Haemonchus/
Haemonchus.html). It is unknown which of the probably
over 50 different expressed cysteine protease genes encode
a product that is present in ES of H. contortus. Considering
the high degree of cysteine activity in ES and their poten-
tial critical function, we decided to fractionate ES of H.
contortus based on the catalytic properties of the cysteine
proteases through a thiol sepharose column to investigate
if the fractions would generate a substantial reduction in
faecal egg counts and worm burden in sheep challenged
with H. contortus.
2. Materials and methods
2.1. Preparation of ES
Adult H. contortus (Moredun strain) were harvested from
the abomasum of donor sheep at 25–35 days post-infection.
ES was obtained as described previously [14] with some
modifications. Briefly, the worms were washed three
times in PBS containing antibiotics (100 I.U./ml penicillin,
100g/ml streptomycin, 5g/ml gentamicin) and incu-
bated at 37 ◦C (5% CO2) in RPMI 1640 (Gibco, Paisley,
UK) containing antibiotics (same concentrations as in PBS).
The medium was changed after 4 h incubation and new
medium added with 2% glucose for overnight incubation
at 37 ◦C. The media from both time points were pooled,
concentrated and desalted (10 mM Tris, pH 7.4) in 3 kDa
filters (Centripep YM3, Millipore).
2.2. Chromatography on Thiol-Sepharose and analysis of
the fractions
ES were applied to a Thiol-Sepharose column as pre-
viously described for membrane extract of H. contortus
[8]. In addition to the elution with 25 mM of cysteine [8]
(Sigma–Aldrich Co., USA), a second elution was performed
with 25 mM Dl-dithiothreitol (DTT, ICN Biomedicals Inc.,
USA). A third elution with 100 mM DTT was introduced to
check for remaining bound proteins to the column. The pep-
tide profiles of the fractions (cysteine-eluted, DTT-eluted
and unbound) was visualised using 2D-SDS–polyacrylamide
gel electrophoresis (2D-SDS–PAGE). ES and the purified
fractions were precipitated in a final concentration of 10%
trichloroacetic acid (TCA, Merck, Germany) containing
10 mM DTT and resuspended in rehydration solution (7 M
urea, 2 M thiourea, 4% CHAPS), 2% carrierampholyte
mixture pH 3–10 non linear (NL) (IPG buffer, Amersham
Biosciences, Germany) and 20 mM DTT. For isoelectric
focusing (IEF) the protein samples (70g protein) were
supplemented with protease inhibitors (Complete pro-
tease Inhibitor Cocktail, Roche, Germany) and loaded on
13 cm IPG strips (pH 3–10 NL). The protocols for IEF
and second dimensional electrophoresis were the same as
described previously [15]. The gels were silver stained,
compared both manually and by Image Master 2D v4.01
software (Amersham Biosciences) in order to correlate
spots to previously made identifications. Zymographic pro-
tease activities were monitored by 1D-gelatin-substrate
analysis under non-reducing conditions [9]. After elec-
trophoresis, the gels were washed three times with 2.5%
Triton-X-100 (Serva, Germany) and incubated with 20 mM
Tris/50 mM NaCl buffer pH 5.0 supplemented with
2 mM DTT. Inhibition experiments were performed with
100M l-transepoxysuccinyl-l-leucylamido-(4-guanidino)-
butane (E64, Roche), 0.4 mM ethylenediaminotetraacetic
acid (EDTA), 1M Pepstatin (Roche), 2 mM 4-(2-amino-
ethyl)-benzenesulfonyl-flouride, hydrochloride (AEBSF,
Pefabloc, Roche), in 20 mM Tris/50 mM NaCl pH 5,0, sup-
plemented with 2 mM DTT. Samples were incubated with
these inhibitors before and after electrophoresis for 30 min
and 20 h, respectively at 37 ◦C. Gels were stained with
Coomassie Blue (0.5% (w/v) in acetic acid:ethanol:water,
1:3.5:5.5, respectively).
2.3. Immunisation trial and parasitological procedures
Twenty-nine Zwart-Bles lambs were reared and kept in-
doors in nematode-free conditions and were 9–9.5 months
old when the experiment started. Five groups, balanced for
sex and weight, were made with six animals per vaccinated
group and five animals in the control group. The lambs
were vaccinated sub cutaneously at week 0, 3 and 6 with
15g of the cysteine-eluted fraction (group 1), 15g of
the DTT-eluted fraction (group 2), 60g of the unbound
fraction (group 3), 75g ES (group 4) per immunisation
and PBS only (group 5). The doses were estimated based
on the yields of the fractionation (described in results).
The antigens or PBS were dissolved in aluminium hydrox-
ide gel (Al(OH)3) (Allhydrogel, Superfos Biosector, Den-
mark) and each animal received 1 mg adjuvant/injection.
All sheep were orally challenged at week 8 with 5000 L3
H. contortus and slaughtered at week 12. The abomasum
was opened immediately to harvest the contents and tissue
biopsies. The empty abomasum was thoroughly washed
with 0.9% saline solution to remove the adhering worms
subsequently. The abomasum was soaked in 0.9% saline at
37 ◦C for 5 h. Worm burdens were measured according to
Eysker and Kooyman [16] on 1:50 aliquots and parasites
were sorted by sex. To determine fecundity, worms were
dissolved in 1% bleachwater and eggs of 20 female worms
were counted per sheep. Faecal samples were collected
every week and after challenge three times a week and the
EPG was measured according to the modified McMaster
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method. Serum samples were collected weekly and stored
at −20 ◦C.
2.4. Isolation of mucus Ig
The abomasal tissue (∼25 cm2) collected at the time
of slaughter was stored until use at −20 ◦C. Mucus iso-
lation was performed according to Kanobana et al. [17].
The protein concentration was measured (Bradford as-
say) and the samples adjusted to a final concentration of
0.5 mg protein/ml for the performance of enzyme linked
immunosorbent assay (ELISA).
2.5. Enzyme linked immunosorbent assay
ELISA plates (96 well, Greiner, Germany) were coated
with 2g/ml ES diluted in 0.06 M carbonate buffer pH
9.6 and incubated for 18 h at room temperature. The plates
were washed three times with milliQ containing 0.05%
Tween-20 in an automatic washer (EL404, Biotek Instru-
ments), blocked with 1% gelatine in PBS and incubated for
1 h at 37 ◦C. Plates were stored at −20 ◦C until use. After
thawing and washing of the plates, serum (1:5 dilution for
IgA/IgE, 1:20 for IgG-isotype ELISA) or mucus (1:10 for
all isotypes) dilutions were added and incubated for 1 h at
37 ◦C. Plates were washed four times and incubated for 1 h
at 37 ◦C with monoclonals anti-sheep IgG, anti-sheep IgA
(Serotec) or anti-sheep IgE (IE7) [18] diluted 1:400 in PBS
containing 0.1% gelatin and 0.05% Tween-20 (PBS-GT).
After washing, the plates were incubated for 1 h at 37 ◦C
with rabbit–anti-mouse immunoglobulin-coupled to alkaline
phosphate (Dako) diluted 1:3000 in PBS-GT. The colori-
metric reaction was developed with p-nitrophenyl phosphate
disodiumsalt (PNPP, Pierce) for 30 min at room tempera-
ture, followed by 18 h incubation at 4 ◦C. Absorbance was
measured at 405 nm. Each individual sample was tested in
duplicate and results are presented as a percentage of the
positive control serum (pool of hyperimmune sheep) that
was present in duplicate on every plate. The hyperimmune
sheep sera were obtained from five animals orally infected
for several times and then challenged with a high dose
of H. contortus. The mucus results were presented in OD
values.
2.6. Lymphocyte proliferation assay (LPA)
Draining lymphnodes were pressed through a fine mesh
to obtain the lymphocytes, which were washed twice with
PBS containing heparin (10 I.E./ml) and adjusted to 2×106
cells/ml in RPMI 1640 containing 10% FCS, 500 I.U./ml
penicillin, 0.5 mg/ml streptomycin and 2 mM l-glutamine.
LPA was performed as previously described [14] with
slight modifications. ES were used at a concentration of
10g/ml and concanavalin A (conA) at 5g/ml. Data are
expressed as stimulation indices (SI) where SI = c.p.m.
(experimental)/c.p.m.(medium control).
2.7. Statistical analysis
The data were statistically analysed through the non-
parametric test of Kruskall–Wallis in the SPSS statistical
package software (Chicago, IL, USA). Differences between
the groups were considered significant at P < 0.05. Pair-
wise comparisons of the groups were calculated by post-hoc
analysis as advised for Kruskall–Wallis. The Bonferroni
correction was applied to avoid false positive associations
generated by the multiple comparison. Correlations between
immunoglobulin levels and parasitological parameters were
analysed with the Spearman’s rank correlation test with
significance at P < 0.01.
3. Results
3.1. Fractionation of ES by Thiol-Sepharose
chromatography
Thiol-binding protein fractions of ES and membrane
proteins of parasitic nematodes have been shown to con-
tain protective properties [7,8]. Theoretically all proteins
containing reduced cysteine residues can bind covalently
to thiol-sepharose. The reactivity and accessibility of the
SH-groups is determined by their sequence context and lo-
cation within the tertiary structure, which also determines
the ease by which bound proteins can be eluted. In addi-
tion, proteins may stick non-covalently with high affinity to
bound proteins although the binding and the washing were
done in a high-ionic strength (0.5 M NaCl) to reduce such
binding. Here, 21% of total ES was bound and eluted in two
steps of increasing strength by successively 25 mM cysteine
(10% of total ES) and 25 mM DTT (11% of total ES). The
third elution with higher DTT concentration (100 mM) did
not contain any protein as checked by analysing a con-
centrated sample on a silver stained gel (data not shown).
This implicates maximally 10-fold enrichment but a more
accurate estimate of the degree of purification of individ-
ual proteins could only be obtained by 2D-PAGE (Fig. 1),
as no specific enzymatic assays or mono-specific antis-
era can be applied here for this purpose. Intensely stained
spots (or groups of spots) exclusively located either in the
eluted fractions or in the unbound fraction are indicated
by square boxes whereas spots present in one of the eluted
fractions and the unbound fraction are enclosed in ovals.
By comparison with the recently established proteomic
map of H. contortus ES [15], identities were assigned to
numbered (groups of) spots and indicated in the legend of
Fig. 1 and Table 1. Their abundance in each fraction was
estimated from spot intensity and documented in Table 1.
Most importantly, several groups of antigens with proposed
protective properties were almost exclusively present in the
unbound fraction. These include the Hc15 (spots 35, 36,
39, 40, 42, 43, see Fig. 1a–d) [6,19], Hc24 (groups 20, 25)
[6,19], Hc40 (group 4) [20] and H11 proteins (group 50)
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[3]. The apical gut protein GA1 spots (group 16) [21] were
predominantly found in the unbound fraction.
3.2. Determination of doses to be used for vaccination
Protease activity was monitored using 6g protein of to-
tal ES, the cysteine-eluted fraction and the unbound fraction
(Fig. 1e, lanes 1, 3 and 5, respectively). The DTT-eluted
fraction showed no activity up to 12g protein (Fig. 1e, lane
4). Protease activity was found to be maximal at pH 5.0 (data
not shown) and activity of total ES was completely inhib-
ited by E64, a cysteine protease inhibitor (Fig. 1e, lane 2).
The total amount of protease activity present in the bound
and unbound fractions seems less than in eluted ES. How-
ever, it must be noted that thiol-binding fraction and subse-
quent elution, especially under harsh conditions containing
25 mM DTT, could lead to permanent inactivation of pro-
teases. Therefore, the amount of protease activity present
in a fraction was not used as a parameter to determine the
doses required for vaccination.
As the proteins present in the two eluted fractions be-
came relatively more enriched than the unbound proteins
(Fig. 1a–c) the doses of immunizations were adjusted based
on the yields of fractionation for each fraction. The animals
from the groups with the two thiol-binding fractions received
15g whereas the group with the unbound fraction received
60g.
3.3. Parasitological parameters
Although not statistically significant, there was a note-
worthy trend for the DTT-eluted group displaying a lesser
egg excretion and worm burden. The DTT-eluted group
(Fig. 2) had a reduction of 52% compared to the adju-
vant control group (Table 2), the animals immunised with
the cysteine-eluted fraction had a 36% reduction in EPG,
while groups 3 and 4, vaccinated with the unbound frac-
tion and ES, respectively, showed 21 and 13% reduction in
EPG. The worm counts (Table 2) followed the same ten-
dency, with group 2 more protected than the other groups.
In groups 1, 2, and 4 more female than male worms were
found (Table 2).
The fecundity values (Fig. 3) revealed that the numbers of
eggs per female found in animals vaccinated with the DTT-
or cysteine-eluted fraction were significantly lower than the
other groups (P < 0.002 with groups 3–5). There was a
significant (P < 0.01) correlation between fecundity and
cumulative EPG (r = 0.56) or worm burden (r = 0.63).

Fig. 1. 2D-SDS–PAGE and gelatine substrate gels of ES derived from parasites harvested of the different thiol-binding fractions of ES of H. contortus
(12.5%). For the fractionation of ES a Thiol-Sepharose column was used. The proteins were eluted in two steps, firstly with 25 mM cysteine (a); secondly
with 25 mM DTT (b); unbound fraction (c) and total ES (d). Rectangles indicate spots present either only in the unbound or in the bound fractions
(cysteine and/or DTT-eluted) and ovals indicate (groups of) spots common to the eluted and unbound fractions. Solid lines represent identifications made
previously by mass spectrometry [15] and dashed lines point out non-identified spots. Some spots in the fractions could not unambiguously be correlated
to spots in the total ES and are therefore not boxed. (e) Protease activity of total ES (lane 1), total ES inhibited by E64 (lane 2), cysteine eluted fraction
(lane 3), DTT-eluted fraction (lane 4) and unbound fraction (lane 5). Molecular weight markers on the left (kDa).
3.4. ELISA
The vaccinated animals had higher ES-specific im-
munoglobulin levels (Fig. 4a–c) compared to the adjuvant
control group. Before challenge at day 56, ES-specific IgG,
IgA and IgE increased significantly after each immuniza-
tion compared to the adjuvant control (G5), as indicated
in Fig. 1a–c. There was a peak 14 days after challenge
for IgG and IgA and for IgE 1 week later. In general, the
cysteine-eluted group (G1) had higher IgG levels than the
other vaccinated groups (Fig. 4a, P < 0.01 at days 35, 56,
77) and total ES group (G4) was higher than all the other
groups 7 days after challenge (P < 0.002, day 63). For IgE,
G2 was the group with highest levels and differed signifi-
cantly from G4 and G5 at days 7 and 49 (P < 0.002) and all
the groups were higher than G4 and G5 after 3 and 4 weeks
of challenge (P < 0.002). For IgA, only day 49 was signifi-
cant and G4 did not differ from adjuvant group, whereas G1
and G2 were higher than all the other groups (P < 0.002).
The mean mucus antibody levels (Fig. 4d) showed local
ES-specific IgA responses more intense than IgG and IgE
responses. Animals vaccinated with the cysteine-eluted frac-
tion had the highest IgA response against ES antigen, but the
response did not differ significantly from the other groups.
3.5. Lymphocyte proliferation assay (LPA)
The ES-specific lymphocyte proliferation responses
(Fig. 5) were more intense, although not significantly, for
DTT-eluted group, compared to other groups. This was
due to two animals (numbers 254 and 274) with low worm
burdens (100 and 650, respectively) and high stimulation
indices (SI of 367 and 90, respectively). As positive control,
all animals showed a proliferative response against conA.
3.6. Protease profiles from the ES of the vaccinated
groups
Zymograms of ES from previous batches (data not shown)
and from five different batches of ES (Fig. 6a, lanes 1–5)
showed that the protease activity of ES from H. contortus
is completely inhibited by E64 (Fig. 6b, lanes 1–5). We
wanted to investigate if the effect of vaccination would in-
fluence the protease activity of the worms retrieved from
the different groups of animals. Therefore, worms were col-
lected from all animals, pooled per group and subsequently
ES were harvested and concentrated. The protease activities
of these products were determined in 1D-gelatin-substrate
N. Bakker et al. / Vaccine 22 (2004) 618–628 623
Table 1
Spots from Fig. 1a–d were marked, numbered and co-localised with the 2D pattern of ES of H. contortus identified previously by proteomic analysis
[15]. In each fraction (cysteine eluted, DTT-eluted or unbound) the presence of each (group of) spot was estimated by crosses (maximum 6)
Spot(s) Protein description (accession number) Fraction
Cysteine eluted DTT eluted Unbound
1 Serpina (Bos taurus, AAF23888) + + + + + +
2 Unknown + + + + + +
3 Unknown + + + + + +
4 Hc40 (AAC03562, BF060098) + + + + + +
5 Unknown + + + + + +
6 Unknown + + + + + +
7 Metallopeptidase mep1 (AAC31568) + + + + + +
8 Metallopeptidase mep2 (AAC28740) + + + + + +
9 Unknown + + + + + +
10 Unknown + + + + + +
11 Serine protease (BF422825) + + + + + +
12 Unknown + + + + + +
13 Apical gut (GA1) (AAB01192) + + + + +
14 Apical gut (GA1) (AAB01192) + + + + + +
15 Glutamate dehydrogenase + + + + +
16 Apical gut (GA1) (AAB01192) + + + + + +
17 Unknown + + + + + +
18 Aldehyde dehydrogenase (BE228187) + + + + + +
19 Unknown + + + + + +
20 H11-2, H11-4 (CAC39009, CAB57358) + + + + + +
21 Unknown + + + + + +
22 Unknown + + + + + +
23 Aldolase (BF642891) + + + + + +
24 Lactate/malate dehydrogenasea (Ascaris suum BM281165) + + + + + +
25 Unknown + + + + + +
26 Hc24 (AAC47714) + + + + + +
27 Hc24 (BF060283, BF059857) + + + + + +
28 Unknown + + + + + +
29 Unknown + + + + + +
30 Unknown + + + + + +
31 Unknown + + + + + +
32 Unknown + + + + + +
33 Transthyretin like domain (BM138829) + + + + + +
34 Hc15 (AAC47713) + + + + + +
35 Hc15 (AAC47713) + + + + + +
36 Hc15 (AAC47713) + + + + + +
37 Unknown + + + + + +
38 Hc15 (AAC47713) + + + + + +
39 Hc15 (AAC47713) + + + + + +
40 Hc15 (AAC47713) + + + + + +
41 Superoxide dismutase (Q27666) + + + + + +
42 Hc15 (AAC47713) + + + + + +
43 Hc15 (AAC47713) + + + + + +
44 Unknown + + + + + +
45 Unknown + + + + + +
46 Unknown + + + + + +
47 Y105C5B.5 (BG734233) + + + + + + + +
48 Unknown + + + + + +
49 Unknown + + + + + +
50 Cyclophilin 3 (BM138858) + + + + + +
a No sequence available from H. contortus, identification was made by similarity to other species [15].
gels. All five groups showed activity in a range from 32 to
200 kDa in the presence of DTT (Fig. 6c). Most of this activ-
ity was inhibited by E64. However, in contrast to a “normal”
profile of previously batches of ES, in the groups vacci-
nated with the DTT-eluted fraction (group 2), ES (group 4),
and the adjuvant control (group 5) a zone of proteolysis re-
mained at around 45 kDa, being particularly prominent in
the DTT-eluted and adjuvant control groups (Fig. 6d, lanes
2, 4, 5). This zone was completely inhibited by the addition
of EDTA to the incubation buffer (data not shown). Based
on the inhibition pattern we concluded that the 45 kDa band
had a metalloprotease profile.
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Fig. 2. Mean faecal egg counts of the animals vaccinated with cysteine-eluted fraction (group 1), with DTT-eluted fraction (group 2), with unbound
fraction (group 3), with ES (group 4) and adjuvant only (group 5).
Table 2
Number of animals per group (N), cumulative faecal egg counts from day 0 till day 27 after challenge (mean± S.E.), percentage of reduction in faecal
egg counts (mean), total worm burden (mean± S.E.), worm burden reduction (mean) and total number of male and female worms (mean) 27 days after
challenge with 5000 L3 H. contortus
Group N Cumulative EPG Reduction
in EPG (%)
Worm burden Reduction in
worm burden (%)
Males Females
1 6 9975 (4352) 35.7 1500 (527) 33.6 642 858
2 6 77521 (1568) 51.5 1124 (239) 50.2 416 708
3 6 112238 (4670) 21.2 1975 (651) 12.6 1025 950
4 6 113433 (4297) 13.4 1916 (503) 15.2 883 1033
5 5 115520 (5646) 2260 (523) 1190 1070
Animals were vaccinated in weeks 0, 3 and 6 with the cysteine-eluted fraction (group 1), DTT-eluted fraction (group 2), unbound fraction (group 3), ES
(group 4) and adjuvant only (group 5).
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Fig. 3. Worm fecundity at 27 days post challenge. Animals were vaccinated with the cysteine-eluted fraction (group 1), DTT-eluted fraction (group
2), unbound fraction (group 3), ES (group 4) and adjuvant only (group 5). Number of eggs per female (mean ± S.E.). Within each group sheep were
divided according to their level of protection (0–20%, 20–60%, 60–100%), i.e. percentage reduction in worm number (a). Number of eggs per female
(mean ± S.E.) per group (b). The symbol (∗) indicates significant difference between the indicated group and group 3–5 (P < 0.002).
4. Discussion
The results indicate that vaccination with the ES thiol-
binding proteins of H. contortus induced partial protection
in sheep after a challenge with 5000 L3 of H. contortus. The
2D protein profiles of the fractions eluted with either cysteine
or DTT revealed a pattern with clear quantitative and quali-
tative differences (Fig. 1). Many spots could be assigned to
proteins of known identity using the recently published pro-
teome map of H. contortus ES [15]. The fractions used for
vaccination documented on silver stained high-resolution
2D gels allows for a future re-evaluation of the current
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Fig. 4. ES-specific IgG (a); IgE (b); IgA (c) (mean ± S.D.) to H. contortus. The animals were vaccinated at week 0, 3 and 6 (arrow) and challenged
at week 8 with 5000 L3 H. contortus (∗). Results are presented as percentage absorbance of the positive control serum. The animals were vaccinated
with the cysteine-eluted fraction (group 1 ()), DTT-eluted fraction (group 2 ()), unbound fraction (group 3 ( )), ES (group 4 ()) and adjuvant
only (group 5 ()). IgA (grey bar), IgG (black bar) and IgE (white bar) mucus antibody levels (mean ± S.D.) at 27 d.p.c. to H. contortus ES (d). The
symbols (#) stands for P < 0.05 and () for P < 0.06 at Kruskal–Wallis.
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Fig. 5. Lymphocyte proliferation response (mean SI± S.E.), 27 days post challenge, to conA (open bar) and H. contortus ES (black bar) in the different
groups vaccinated with the cysteine-eluted fraction (group 1), DTT-eluted fraction (group 2), unbound fraction (group 3), ES (group 4) and adjuvant
only (group 5).
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Fig. 6. Gelatine substrate gels of ES incubated before and after electrophoresis with DTT (a and c) or with E64 and DTT (b and d). Five different
batches of ES harvested from donor sheep (5g per lane, a and b) and ES derived from parasites harvested from the five different vaccinated groups
(10g/lane, c and d). Group 1 vaccinated with cysteine-eluted fraction, group 2 with DTT-eluted fraction, group 3 with unbound fraction, group 4 with
ES and group 5 with adjuvant only. Molecular weight markers are indicated on the left in kilodalton.
experiment when the identities of additional spots become
resolved. Standard used 1D gels clearly do not support this
type of update and, moreover, underestimate the complex-
ity of partially purified fractions. The DTT-eluted fraction
conferred more protection (50%) than the cysteine-eluted
fraction (34%) whereas the group vaccinated with total ES
showed a reduction around 15% in EPG and worm burden,
lower levels compared to a previous experiment, where
reductions in the same parameters were 32 and 63%, re-
spectively [14]. The present experiment used Al(OH)3 as
adjuvant, whilst diethyl dioctadecyl ammonium bromide
(DDA) was used in the former [22]. DDA induces a Th-1
response while Al(OH)3 induces a strong Th-2 response
[23]. However, in another recent study in our department,
sheep vaccinated with ES in Al(OH)3 showed high percent-
age reductions in both EPG and worm burden (89 and 77%)
compared to the adjuvant alone controls suggesting that the
adjuvant is not the reason for the different protection levels
found here and previously [22]. We recently demonstrated
that the 2D profiles of different batches of ES show no
major differences [15], although it cannot be excluded that
also very small differences can have an effect on protective
properties.
We deliberately decided for a lower dose based on the
proportion of the thiol-binding proteins in total ES, thus the
amount of antigen (15g) used in this experiment was lower
when compared to other vaccination trials with H. contortus,
in which between 50 and 200g was used [5,8,22,24,25].
Increasing the amount of a fractionated antigen administered
could possibly increase the relevant immune response and,
with it, the level of protection observed.
The number of eggs per female found in worms from the
groups vaccinated with the DTT- or cysteine-eluted frac-
tions was significantly lower compared to the other groups
(Fig. 3). A positive relation was found between fecundity,
EPG and worm burden. Vaccination of sheep and cattle with
fractions enriched for cysteine protease also induced a sig-
nificant decrease in worm fecundity of Fasciola hepatica
[26] and O. ostertagi [7].
The vaccination schedule induced particularly marked in-
creases in serum levels of antigen-specific IgG with lesser
intensities in IgA and IgE levels (Fig. 4). In contrast, mucus
antibody levels, a measure of the local immune response,
were only elevated for IgA compared to the controls. No
correlation was found between fecundity or protection and
antibody levels in serum and mucus. Serum IgG antibody
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levels have been correlated with protection using, for ex-
ample, H11 as antigen [27,28]. Local parasite-specific IgA
responses have been associated with reduced fecundity of
O. circumcincta [29] in sheep and of O. ostertagi [7] in
calves but the correlations in this last experiment were low
(r = −0.36). Studies using purified larval surface antigens,
cuticular collagen proteins or total H. contortus for immuni-
sation had no clear relation between specific antibody levels
and the protection status of the sheep [5,24,30,31].
We analysed the protease activity profiles of ES de-
rived from worms retrieved from vaccinated animals after
necropsy. Cysteine protease activity was detected in all
groups, but metalloprotease activity was also present in
the group vaccinated with the DTT-eluted fraction, the
adjuvant control group and less clearly in ES-vaccinated
group (Fig. 6c–d). Metalloprotease activity was absent from
five different batches of ES that were previously tested, as
shown by complete inhibition by E64 at pH 5.0, but also at
pH 3.0 and 8.0 (data not shown).
The differing degrees of protection observed for the
two thiol-binding fractions, cysteine eluted (50%) and
the DTT-eluted (34%) could mean that the DTT fraction
contains unique protective components or that a common
component is more abundant in the DTT fraction. The ab-
sence of protease activity in the DTT-eluted fraction could
be explained by inactivation, as the concentration of DTT
(25 mM) used to elute the proteins may have irreversibly
altered the protease structure. This is an inherent limitation
correlating protection to enzymatic activity as measured
for instance by zymograms as inactivated enzymes can
still induce immune responses. To obtain more insight, we
co-localised as many as spots as possible with the previous
identified ones [15]. There are a few groups of spots left,
with predicted molecular weights around 30–40 kD, that
could possibly represent cysteine proteases (for example
groups 3, 21, 24 and 25 and other unmarked spots below
group 24, Fig. 1a and b). There are several unknown pro-
teins predominantly and exclusively present in the DTT
fraction, such as spots 6, 9, 10, 17, 19, 44 (Table 1), which
represent interesting groups to be identified, as this was
the fraction giving highest protection. Obviously further
fractionation will remain necessary to identify proteins re-
sponsible for the conferred protection, as abundant spots do
not necessarily correlate a higher degree of immunity. This
is a problem often overlooked when relying exclusively in
1D gel analysis, since in other studies with gastrointestinal
nematodes fractionated extracts were tested in vaccinations
as a first-step identification of possible protective antigens
[7,8,21,22,32,33,34].
In conclusion, we have demonstrated protective prop-
erties of ES thiol-binding proteins which may contain
cysteine proteases, as confirmed previously for membrane
protein thiol-binding proteins [8]. In addition, other groups
of known and unknown proteins were shown to be present
in these fractions that might contribute to the protective
effects. Their precise documentation by 2D protein gel anal-
ysis will facilitate a better evaluation of future studies on
differently or more extensively purified fractions and will
hopefully lead to the selection of specific gene products to
be tested in a recombinant vaccine.
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